1,092 results on '"Valle, Juan W."'
Search Results
2. ASO Visual Abstract: Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease
3. Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapy
4. Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
5. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
6. Radiomics and outcome prediction to antiangiogenic treatment in advanced gastroenteropancreatic neuroendocrine tumours: findings from the phase II TALENT trial
7. Perspective on Immunotherapy Use in Biliary Tract Cancer
8. Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma
9. The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study
10. ‘IHPBA-APHPBA clinical practice guidelines’: international Delphi consensus recommendations for gallbladder cancer
11. Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma
12. Immunobiology of cholangiocarcinoma
13. Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours
14. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
15. Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter
16. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
17. NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma
18. Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
19. Hepatopancreaticobiliary Cancer in Older Adults with Frailty
20. Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial
21. Choosing the best systemic treatment sequence for control of tumour growth in gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): What is the recent evidence?
22. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis and prognostication of cholangiocarcinoma
23. Intrahepatic cholangiocarcinoma hidden within cancer of unknown primary
24. Corrigendum to “Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours” [Eur J Cancer 188 (2023) 39–48]
25. Intrahepatic Cholangiocarcinoma With Extrahepatic Metastasis and High Tumor Mutation Burden: Case of Complete Pathological Response to Cisplatin/Gemcitabine/Pembrolizumab
26. Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group
27. Clinical challenges associated with utility of neoadjuvant treatment in patients with pancreatic ductal adenocarcinoma
28. Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy
29. Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial
30. Chemotherapy for Advanced Pancreatic Cancer: Available Drugs, Mechanisms and Toxicity
31. Somatostatin Receptor Imaging with [18F]FET-bAG-TOCA PET/CT and [68Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative Study.
32. Perspective on Immunotherapy Use in Biliary Tract Cancer
33. Somatostatin Receptor Imaging with [18F]FET-βAG-TOCA PET/CT and [68Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative Study
34. Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study
35. Clinical benefit of surveillance after resection of pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
36. Chemotherapy for advanced gallbladder cancer (GBC): A systematic review and meta-analysis
37. Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group
38. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
39. HPB cancers in older patients | inclusion of older/senior patients in clinical trials
40. Outcomes in older patients with biliary tract cancer
41. Systemic therapies in advanced hepatocellular carcinoma: How do older patients fare?
42. Lung Neuroendocrine Tumours
43. Non-Functioning Pancreatic Neuroendocrine Tumours
44. Impact on prognosis of early weight loss during palliative chemotherapy in patients diagnosed with advanced pancreatic cancer
45. Novel Treatments for Advanced Cholangiocarcinoma
46. Molecular targeted therapies: Ready for “prime time” in biliary tract cancer
47. Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Analysis
48. The assessment of pancreatic exocrine function in patients with inoperable pancreatic cancer: In need of a new gold-standard
49. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial
50. The clinical and cost-effectiveness of supplemental parenteral nutrition in oncology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.